Ubiquitination-mediated regulation of interferon responses

References

• Ali S, Nouhi Z, Chughtai N. 2003. SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor. J Biol Chem. 278:52021–52031.
   PubMedGoogle Scholar
• Ashour J, Laurent-Rolle M, Shi PY, Garcia-Sastre A. 2009. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol. 83:5408–5418.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, HuangFu WC, Liu J, Veeranki S, Baker DP, Koumenis C, Diehl JA, Fuchs Y. 2010. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor. J Biol Chem. 285:2318–2325.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Zheng H, Tzimas C, Carroll M, Baker DP, Fuchs Y. 2011. Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNalpha via accelerating the degradation of its receptor. Blood. 118:4179–4187.
   PubMed Web of Science ®Google Scholar
• Bibeau-Poirier A, Servant J. 2008. Roles of ubiquitination in pattern-recognition receptors and type I interferon receptor signaling. Cytokine. 43:359–367.
   PubMedGoogle Scholar
• Boname JM, Lehner J. 2011. What has the study of the K3 and K5 viral ubiquitin E3 ligases taught us about ubiquitin-mediated receptor regulation?. Viruses. 3:118–131.
   Google Scholar
• Boname JM, de Lima BD, Lehner PJ, Stevenson G. 2004. Viral degradation of the MHC class I peptide loading complex. Immunity. 20:305–317.
   Google Scholar
• Boname JM, Thomas M, Stagg HR, Xu P, Peng J, Lehner J. 2010. Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic. 11:210–220.
   PubMed Web of Science ®Google Scholar
• Bonnet MC, Weil R, Dam E, Hovanessian AG, Meurs F. 2000. PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol Cell Biol. 20:4532–4542.
   PubMed Web of Science ®Google Scholar
• Burr ML, Cano F, Svobodova S, Boyle LH, Boname JM, Lehner J. 2011. HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation. Proc Natl Acad Sci USA. 108:2034–2039.
   PubMed Web of Science ®Google Scholar
• Chen ZJ. 2005. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol. 7:758–765.
   PubMed Web of Science ®Google Scholar
• Cho IR, Oh M, Koh SS, Malilas W, Srisuttee R, Jhun BH, Pallegrini S, Fuchs SY, Chung YH. 2012. Hepatitis B virus X protein inhibits extracellular IFN-alpha-mediated signal transduction by downregulation of type I IFN receptor. Int J Mol Med. 29:581–586.
   Google Scholar
• Chu WM, Ostertag D, Li ZW, Chang L, Chen Y, Hu Y, Williams B, Perrault J, Karin M. 1999. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity. 11:721–731.
   PubMed Web of Science ®Google Scholar
• Crow MK, Kirou A. 2004. Interferon-alpha in systemic lupus erythematosus. Curr Opin Rheumatol. 16:541–547.
   PubMed Web of Science ®Google Scholar
• Datta S, Hazari S, Chandra PK, Samara M, Poat B, Gunduz F, Wimley WC, Hauser H, Koster M, Lamaze C, Balart LA, Garry RF, Dash S. 2011. Mechanism of HCV's resistance to IFN-alpha in cell culture involves expression of functional IFN-alpha receptor 1. Virol J. 8:351.
   Google Scholar
• de Bie P, Ciechanover A. 2011. Ubiquitination of E3 ligases: Self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms. Cell Death Differ. 18:1393–1402.
   PubMed Web of Science ®Google Scholar
• Donnelly RP, Kotenko V. 2010. Interferon-lambda: A new addition to an old family. J Interferon Cytokine Res. 30:555–564.
   PubMed Web of Science ®Google Scholar
• Douglas JL, Gustin JK, Viswanathan K, Mansouri M, Moses AV, Fruh K. 2010. The great escape: Viral strategies to counter BST-2/tetherin. PLoS Pathog. 6:e1000913.
   PubMedGoogle Scholar
• Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, Burrows JF, Buick R, Stevenson NJ, Touzelet O, Gadina M, Power UF, Johnston A. 2007. Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol. 81:3428–3436.
   PubMed Web of Science ®Google Scholar
• Fuchs SY. 2002. The role of ubiquitin-proteasome pathway in oncogenic signaling. Cancer Biol Ther. 1:337–341.
   PubMed Web of Science ®Google Scholar
• Fuchs SY, Spiegelman VS, Kumar G. 2004. The many faces of beta-TrCP E3 ubiquitin ligases: Reflections in the magic mirror of cancer. Oncogene. 23:2028–2036.
   PubMed Web of Science ®Google Scholar
• Gao C, Guo H, Mi Z, Grusby MJ, Kuo C. Osteopontin induces ubiquitin-dependent degradation of STAT1 in RAW264.7 murine macrophages. J Immunol. 2007a; 178:1870–1881.
   Google Scholar
• Gao C, Mi Z, Guo H, Kuo C. Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells. Neoplasia. 2007b; 9:699–706.
   Google Scholar
• Garcin D, Marq JB, Strahle L, le Mercier P, Kolakofsky D. 2002. All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology. 295:256–265.
   PubMed Web of Science ®Google Scholar
• Gauzzi MC, Barbieri G, Richter MF, Uze G, Ling L, Fellous M, Pellegrini S. 1997. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. Proc Natl Acad Sci USA. 94:11839–11844.
   PubMed Web of Science ®Google Scholar
• Goila-Gaur R, Strebel K. 2008. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology. 5:51.
   PubMed Web of Science ®Google Scholar
• Guo H, Mi Z, Bowles DE, Bhattacharya SD, Kuo C. 2010. Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages. J Biol Chem. 285:37787–37796.
   Google Scholar
• Hewitt EW, Duncan L, Mufti D, Baker J, Stevenson PG, Lehner J. 2002. Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J. 21:2418–2429.
   PubMedGoogle Scholar
• Huangfu WC, Fuchs Y. 2010. Ubiquitination-dependent regulation of signaling receptors in cancer. Genes Cancer. 1:725–734.
   PubMedGoogle Scholar
• Huangfu WC, Qian J, Liu C, Liu J, Lokshin AE, Baker DP, Rui H, Fuchs SY. 2012. Inflammatory signaling compromises cell responses to interferon alpha. Oncogene. 31:161–172.
   PubMed Web of Science ®Google Scholar
• Ishii T, Kwon H, Hiscott J, Mosialos G, Koromilas E. 2001. Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR. Oncogene. 20:1900–1912.
   PubMedGoogle Scholar
• Jackson PK. 2001. A new RING for SUMO: Wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15:3053–3058.
   PubMedGoogle Scholar
• Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, Hattori K, Hatakeyama S, Yada M, Morita S, Kitamura T, Kato H, Nakayama K, Yoshimura A. 2001. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem. 276:12530–12538.
   PubMed Web of Science ®Google Scholar
• Kamura T, Sato S, Haque D, Liu L, Kaelin WGJr, Conaway RC, Conaway W. 1998. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:3872–3881.
   PubMed Web of Science ®Google Scholar
• Kim TK, Maniatis T. 1996. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science. 273:1717–1719.
   PubMed Web of Science ®Google Scholar
• Kirkin V, Dikic I. 2011. Ubiquitin networks in cancer. Curr Opin Genet Dev. 21:21–28.
   PubMed Web of Science ®Google Scholar
• Komuro A, Bamming D, Horvath M. 2008. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine. 43:350–358.
   Google Scholar
• Kumar KG, Tang W, Ravindranath AK, Clark WA, Croze E, Fuchs Y. 2003. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J. 22:5480–5490.
   PubMed Web of Science ®Google Scholar
• Kumar KG, Krolewski JJ, Fuchs Y. 2004. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J Biol Chem. 279:46614–46620.
   PubMed Web of Science ®Google Scholar
• Kumar KG, Barriere H, Carbone CJ, Liu J, Swaminathan G, Xu P, Li Y, Baker DP, Peng J, Lukacs GL, Fuchs Y. 2007. Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J Cell Biol. 179:935–950.
   PubMed Web of Science ®Google Scholar
• Kumar KG, Varghese B, Banerjee A, Baker DP, Constantinescu SN, Pellegrini S, Fuchs Y. 2008. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif. J Biol Chem. 283:18566–18572.
   PubMed Web of Science ®Google Scholar
• Le VT, Trilling M, Wilborn M, Hengel H, Zimmermann A. 2008. Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J Gen Virol. 89:2416–2426.
   PubMed Web of Science ®Google Scholar
• Lee Y, Hyung SW, Jung HJ, Kim HJ, Staerk J, Constantinescu SN, Chang EJ, Lee ZH, Lee SW, Kim H. 2008. The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-beta-induced inhibitory signaling. Blood. 111:885–893.
   Google Scholar
• Lehner PJ, Hoer S, Dodd R, Duncan M. 2005. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol Rev. 207:112–125.
   Google Scholar
• Liberatore RA, Bieniasz D. 2011. Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo. Proc Natl Acad Sci USA. 108:18097–18101.
   PubMed Web of Science ®Google Scholar
• Liu J, HuangFu WC, Kumar KG, Qian J, Casey JP, Hamanaka RB, Grigoriadou C, Aldabe R, Diehl JA, Fuchs Y. 2009. Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe. 5:72–83.
   PubMed Web of Science ®Google Scholar
• Li Y, Gazdoiu S, Pan ZQ, Fuchs Y. 2004. Stability of homologue of Slimb F-box protein is regulated by availability of its substrate. J Biol Chem. 279:11074–11080.
   Google Scholar
• Li Q, Means R, Lang S, Jung U. 2007. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J Virol. 81:2117–2127.
   PubMed Web of Science ®Google Scholar
• Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, Piguet V. 2009. HIV-1 Vpu neutralizes the antiviral factor tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 5:e1000574.
   PubMed Web of Science ®Google Scholar
• Mansouri M, Viswanathan K, Douglas JL, Hines J, Gustin J, Moses AV, Fruh K. 2009. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J Virol. 83:9672–9681.
   PubMed Web of Science ®Google Scholar
• Marijanovic Z, Ragimbeau J, Kumar KG, Fuchs SY, Pellegrini S. 2006. TYK2 activity promotes ligand-induced IFNAR1 proteolysis. Biochem J. 397:31–38.
   PubMedGoogle Scholar
• Minakshi R, Padhan K, Rani M, Khan N, Ahmad F, Jameel S. 2009. The SARS coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor. PLoS One. 4:e8342.
   PubMed Web of Science ®Google Scholar
• Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli C. 2009. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5:e1000450.
   PubMed Web of Science ®Google Scholar
• Nie L, Zhao Y, Wu W, Yang YZ, Wang HC, Sun H. 2011. Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes. Cell Res. 21:754–769.
   Google Scholar
• Pardieu C, Vigan R, Wilson SJ, Calvi A, Zang T, Bieniasz P, Kellam P, Towers GJ, Neil J. 2010. The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog. 6:e1000843.
   PubMed Web of Science ®Google Scholar
• Payelle-Brogard B, Pellegrini S. 2010. Biochemical monitoring of the early endocytic traffic of the type I interferon receptor. J Interferon Cytokine Res. 30:89–98.
   Google Scholar
• Pfeffer LM. 2011. The role of nuclear factor kappaB in the interferon response. J Interferon Cytokine Res. 31:553–559.
   PubMed Web of Science ®Google Scholar
• Piganis RA, De Weerd NA, Gould JA, Schindler CW, Mansell A, Nicholson SE, Hertzog J. 2011. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2. J Biol Chem. 286:33811–33818.
   PubMed Web of Science ®Google Scholar
• Platanias LC. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 5:375–386.
   PubMed Web of Science ®Google Scholar
• Poat B, Hazari S, Chandra PK, Gunduz F, Balart LA, Alvarez X, Dash S. 2010. SH2 modified STAT1 induces HLA-I expression and improves IFN-gamma signaling in IFN-alpha resistant HCV replicon cells. PLoS One. 5:e13117.
   Google Scholar
• Precious B, Childs K, Fitzpatrick-Swallow V, Goodbourn S, Randall E. 2005. Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J Virol. 79:13434–13441.
   PubMed Web of Science ®Google Scholar
• Puri M, Lemon K, Duprex WP, Rima BK, Horvath M. 2009. A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting. J Virol. 83:6347–6356.
   PubMedGoogle Scholar
• Qian J, Zheng H, Huangfu WC, Liu J, Carbone CJ, Leu NA, Baker DP, Fuchs Y. 2011. Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1. PLoS Pathog. 7:e1002065.
   PubMed Web of Science ®Google Scholar
• Ragimbeau J, Dondi E, Alcover A, Eid P, Uze G, Pellegrini S. 2003. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J. 22:537–547.
   PubMedGoogle Scholar
• Ramachandran A, Horvath M. 2009. Paramyxovirus disruption of interferon signal transduction: STATus report. J Interferon Cytokine Res. 29:531–537.
   Google Scholar
• Ren J, Kolli D, Liu T, Xu R, Garofalo RP, Casola A, Bao X. 2011. Human metapneumovirus inhibits IFN-beta signaling by downregulating Jak1 and Tyk2 cellular levels. PLoS One. 6:e24496.
   Google Scholar
• Schmidt K, Wies E, Neipel F. 2011. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression. J Virol. 85:4530–4537.
   Google Scholar
• Seth RB, Sun L, Chen J. 2006. Antiviral innate immunity pathways. Cell Res. 16:141–147.
   PubMed Web of Science ®Google Scholar
• Shah KM, Stewart SE, Wei W, Woodman CB, O'Neil JD, Dawson CW, Young S. 2009. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. Oncogene. 28:3903–3914.
   Google Scholar
• Soond SM, Townsend PA, Barry SP, Knight RA, Latchman DS, Stephanou A. 2008. ERK and the F-box protein betaTRCP target STAT1 for degradation. J Biol Chem. 283:16077–16083.
   PubMedGoogle Scholar
• Straub CP, Lau WH, Preston FM, Headlam MJ, Gorman JJ, Collins PL, Spann M. 2011. Mutation of the elongin C binding domain of human respiratory syncytial virus non-structural protein 1 (NS1) results in degradation of NS1 and attenuation of the virus. Virol J. 8:252.
   Google Scholar
• Tanaka T, Soriano MA, Grusby J. 2005. SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling. Immunity. 22:729–736.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Yamamoto Y, Muromoto R, Ikeda O, Sekine Y, Grusby MJ, Kaisho T, Matsuda T. 2011. PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3. Sci Signal. 4:ra85.
   PubMed Web of Science ®Google Scholar
• Tenno T, Fujiwara K, Tochio H, Iwai K, Morita EH, Hayashi H, Murata S, Hiroaki H, Sato M, Tanaka K, Shirakawa M. 2004. Structural basis for distinct roles of Lys63- and Lys48-linked polyubiquitin chains. Genes Cells. 9:865–875.
   PubMed Web of Science ®Google Scholar
• Trilling M, Le VT, Fiedler M, Zimmermann A, Bleifuss E, Hengel H. 2011. Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-gamma-stimulated cells. PLoS Pathog. 7:e1002069.
   Google Scholar
• Ulane CM, Horvath M. 2002. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology. 304:160–166.
   PubMedGoogle Scholar
• Ulane CM, Rodriguez JJ, Parisien JP, Horvath M. 2003. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J Virol. 77:6385–6393.
   PubMed Web of Science ®Google Scholar
• Ulane CM, Kentsis A, Cruz CD, Parisien JP, Schneider KL, Horvath M. 2005. Composition and assembly of STAT-targeting ubiquitin ligase complexes: Paramyxovirus V protein carboxyl terminus is an oligomerization domain. J Virol. 79:10180–10189.
   PubMedGoogle Scholar
• Ungureanu D, Silvennoinen O. 2005. SLIM trims STATs: Ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling. Sci STKE. 2005:pe49.
   Google Scholar
• Ungureanu D, Saharinen P, Junttila I, Hilton DJ, Silvennoinen O. 2002. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol. 22:3316–3326.
   PubMed Web of Science ®Google Scholar
• Uze G, Schreiber G, Piehler J, Pellegrini S. 2007. The receptor of the type I interferon family. Curr Top Microbiol Immunol. 316:71–95.
   PubMedGoogle Scholar
• Viswanathan K, Fruh K, DeFilippis V. 2010. Viral hijacking of the host ubiquitin system to evade interferon responses. Curr Opin Microbiol. 13:517–523.
   PubMed Web of Science ®Google Scholar
• Viswanathan K, Smith MS, Malouli D, Mansouri M, Nelson JA, Fruh K. 2011. BST2/tetherin enhances entry of human cytomegalovirus. PLoS Pathog. 7:e1002332.
   Google Scholar
• Yang CH, Murti A, Pfeffer SR, Fan M, Du Z, Pfeffer M. 2008. The role of TRAF2 binding to the type I interferon receptor in alternative NF kappaB activation and antiviral response. J Biol Chem. 283:14309–14316.
   Google Scholar
• Yokosawa N, Yokota S, Kubota T, Fujii N. 2002. C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J Virol. 76:12683–12690.
   Google Scholar
• Yu J, Li X, Wang Y, Li B, Li H, Li Y, Zhou W, Zhang C, Rao Z, Bartlam M, Cao Y. 2011. PDlim2 selectively interacts with the PDZ binding motif of highly pathogenic avian H5N1 influenza A virus NS1. PLoS One. 6:e19511.
   Google Scholar
• Zhang D, Zhang E. 2011. Interferon-stimulated gene 15 and the protein ISGylation system. J Interferon Cytokine Res. 31:119–130.
   PubMedGoogle Scholar
• Zheng H, Qian J, Baker DP, Fuchs Y. Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor. J Biol Chem. 2011a; 286:35733–35741.
   PubMed Web of Science ®Google Scholar
• Zheng H, Qian J, Carbone CJ, Leu NA, Baker DP, Fuchs Y. Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis. Blood. 2011b; 118:4003–4006.
   PubMed Web of Science ®Google Scholar
• Zheng H, Qian J, Varghese B, Baker DP, Fuchs S. Ligand-stimulated downregulation of the alpha interferon receptor: Role of protein kinase D2. Mol Cell Biol. 2011c; 31:710–720.
   PubMed Web of Science ®Google Scholar